Latest Strategy News

Litchfield Minerals has intersected approximately 46 metres of disseminated copper-iron sulphides at its VT1 conductor in the Northern Territory, initiating a detailed downhole electromagnetic survey to refine drilling targets and accelerate exploration.

Lumos Diagnostics reported steady quarterly revenue with a 300% surge in product sales, driven by its flagship FebriDx® test. The company inked a landmark US$317 million exclusive U.S. distribution agreement and awaits FDA feedback on its CLIA waiver application.

Insurance Australia Group (IAG) reported strong FY25 results and upgraded its FY26 guidance, reflecting the completed RACQ acquisition and ongoing strategic growth initiatives.

Forrestania Resources Limited is set to update investors on its rapidly expanding gold resource base and strategic acquisitions in Western Australia during an upcoming webinar. The company’s disciplined approach targets production-ready assets to drive shareholder value.

Fortescue Metals Group kicked off FY26 with record iron ore shipments and strengthened its decarbonisation strategy through new partnerships and a $2 billion Renminbi loan.

Insignia Financial reported a 3.1% rise in Funds Under Management and Administration to $340.5 billion, driven by strong net inflows into its Wrap platform and strategic enhancements to its MLC offerings. The company also completed a key custody transition and unveiled a refreshed MLC brand campaign.

Audeara Ltd has reported a remarkable 111% revenue increase in Q1 FY26, driven by strong growth in its technology division and key international partnerships in China and Japan. The company is advancing towards cashflow breakeven with improved cash management and expanding global reach.

Insurance Australia Group (IAG) has upgraded its FY26 financial guidance following the acquisition of RACQ’s insurance business, projecting stronger premium growth and higher profits.

Brambles Limited reported robust FY25 financial results and sustainability achievements, highlighting a $1 billion free cash flow milestone and ambitious 2030 regenerative targets at its 2025 AGM.

Firebrick Pharma reports a $1.94 million cash reserve after a $1.4 million placement, supporting expanded Nasodine sales across Southeast Asia and the US. Board changes and increased operational costs mark a pivotal quarter for the pharmaceutical innovator.

VRX Silica Limited has secured four binding offtake contracts for 410,000 tonnes per annum of silica sand from its Arrowsmith North project, representing nearly half of its initial production capacity and marking a significant commercial milestone.

Cochlear Limited reports steady FY25 financials alongside the launch of its innovative Nucleus Nexa cochlear implant system, setting the stage for projected double-digit profit growth in FY26.